Bluestone Jeffrey 4
4 · GILEAD SCIENCES, INC. · Filed Jul 15, 2025
Insider Transaction Report
Form 4
Bluestone Jeffrey
Director
Transactions
- Sale
Common Stock
2025-07-14$109.74/sh−5,000$548,700→ 8,920 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-07-14−5,000→ 9,665 totalExercise: $67.45Exp: 2031-05-12→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2025-07-14$67.45/sh+5,000$337,250→ 13,920 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.
- [F2]25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.